Most Read Articles
Elvira Manzano, 4 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
20 hours ago
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.
Pearl Toh, 13 Oct 2017
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.
Tristan Manalac, 22 hours ago
Statin use, particularly in smokers, obese patients and nondiabetics, has a strong and dose-dependent association with decreasing risk of pancreatic ductal adenocarcinoma (PDAC), according to a new study.

Bariatric surgery does not guarantee improvement, prevention of DR

06 Sep 2017

Bariatric surgery does not appear to help thwart the progression of diabetic retinopathy (DR), with young male patients having pre-existing DR and poor preoperative glycaemic control being at greatest risk of progression, a study has found.

The study included 102 type 2 diabetes mellitus patients (median age 55 years; 33.3 percent male) who underwent bariatric surgery between 2009 and 2015. Patients were followed for a median of 4 years, and data on preoperative and postoperative weight, glycated haemoglobin (HbA1c) and annual DR screening were collected and analysed.

Prior to the operation, there were 69 patients without DR, 31 with background retinopathy, one with preproliferative retinopathy and one with proliferative retinopathy.

Following bariatric surgery, 19 percent of patients developed new DR by the first postoperative visit. Majority (70 percent) remained stable, while 11 percent improved. These proportions remained similar for each postoperative visit over time, with the incidence of developing new DR ranging from 19 to 7 percent and the proportion of patients deteriorating from previous screening ranging from 10 to 5 percent.

On logistic regression analysis, young age, male gender, high preoperative HbA1c and presence of preoperative retinopathy emerged as significant predictors of postoperative DR worsening.

Given the finding that bariatric surgery does not guarantee improvement or prevention of DR, researchers recommended that all diabetic patients attend regular DR screening after bariatric surgery to allow early detection of potentially sight-threatening changes, particularly among those with identifiable risk factors.

Additional prospective studies with longer follow-up are needed to shed light on the duration of DR progression risk.

Editor's Recommendations
Most Read Articles
Elvira Manzano, 4 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
20 hours ago
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.
Pearl Toh, 13 Oct 2017
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.
Tristan Manalac, 22 hours ago
Statin use, particularly in smokers, obese patients and nondiabetics, has a strong and dose-dependent association with decreasing risk of pancreatic ductal adenocarcinoma (PDAC), according to a new study.